(Q37990043)

26 August 2017

title

Psoriasis and physical activity: a review (English)

1 reference

26 August 2017

P B Wilson

1

1 reference

26 August 2017

K A Bohjanen

series ordinal

2

1 reference

26 August 2017

S J Ingraham

series ordinal

3

1 reference

26 August 2017

A S Leon

series ordinal

4

1 reference

26 August 2017

publication date

5 March 2012

1 reference

Journal of the European Academy of Dermatology and Venereology

26 August 2017

published in

1 reference

26 August 2017

volume

26

1 reference

26 August 2017

issue

11

1 reference

26 August 2017

page(s)

1345-1353

1 reference

AJC editor's consensus: psoriasis and coronary artery disease.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Prevalence of metabolic syndrome in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Psoriasis and metabolic disease: epidemiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Exercise for prevention and treatment of cardiovascular disease, type 2 diabetes, and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Integrative dermatology for psoriasis: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Physical activity in men and women with arthritis National Health Interview Survey, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Cardiovascular risk factors, fitness and physical activity in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Impact of psoriasis on quality of life in Kuwait

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Alcohol intake and risk of incident psoriasis in US women: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Reproducibility and validity of a self-administered physical activity questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Association between psoriasis and incident cancer: the Iowa's Women's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

A novel multidisciplinary educational programme for patients with chronic skin diseases: Ghent pilot project and first results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Adipose tissue, adipokines, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Serum leptin levels, skin leptin and leptin receptor expression in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Leptin and coronary heart disease: prospective study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Obesity, adiponectin and vascular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Review on leptin and adiponectin responses and adaptations to acute and chronic exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Remission of psoriasis after open gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Exercise accelerates cutaneous wound healing and decreases wound inflammation in aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Interleukin-6 and diabetes: the good, the bad, or the indifferent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Interferon gamma: a master regulator of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Elevated rate of Thelper1 (TH1) lymphocytes and serum IFN-γ levels in psoriatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Review of the relationship between C-reactive protein and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Oxidative stress in the pathogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Relationship between physical activity and oxidative stress biomarkers in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Oxidative stress and antioxidant defense system in healthy, elderly men: relationship to physical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Effect of exercise on oxidative stress: a 12-month randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Acute prolonged exercise reduces moderately oxidized LDL in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Efalizumab binding to the LFA-1 L I domain blocks ICAM-1 binding via steric hindrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Chronic exercise reduces adhesion molecules/iNOS expression and partially reverses vascular responsiveness in hypercholesterolemic rabbit aortae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Epigenetics: a landscape takes shape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Epigenetics in human autoimmunity. Epigenetics in autoimmunity - DNA methylation in systemic lupus erythematosus and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Physical activity and global genomic DNA methylation in a cancer-free population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Cutting edge: ASC mediates the induction of multiple cytokines by Porphyromonas gingivalis via caspase-1-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

A survey of the social and psychological effects of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

A study of psoriasis and quality of life in a tertiary care teaching hospital of kottayam, kerala

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

Reduced oxidized LDL levels after a 10-month exercise program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

ECSS position statement: Exercise and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04494.X

10.1111/J.1468-3083.2012.04494.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference